[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2610 Reported in Senate (RS)]

                                                       Calendar No. 273

105th CONGRESS

  1st Session

                               H. R. 2610

_______________________________________________________________________

                                 AN ACT

 To amend the National Narcotics Leadership Act of 1988 to extend the 
  authorization for the Office of National Drug Control Policy until 
 September 30, 1999, to expand the responsibilities and powers of the 
 Director of the Office of National Drug Control Policy, and for other 
                               purposes.

_______________________________________________________________________

                            November 6, 1997

                       Reported with an amendment
                                                       Calendar No. 273
105th CONGRESS
  1st Session
                                H. R. 2610


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            October 22, 1997

  Received; read twice and referred to the Committee on the Judiciary

                            November 6, 1997

                Reported by Mr. Hatch, with an amendment
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

_______________________________________________________________________

                                 AN ACT


 
 To amend the National Narcotics Leadership Act of 1988 to extend the 
  authorization for the Office of National Drug Control Policy until 
 September 30, 1999, to expand the responsibilities and powers of the 
 Director of the Office of National Drug Control Policy, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

<DELETED>SECTION 1. SHORT TITLE; AMENDMENT REFERENCES.</DELETED>

<DELETED>    (a) Short Title.--This Act may be cited as the ``National 
Narcotics Leadership Act Amendments of 1997''.</DELETED>
<DELETED>    (b) Amendment References.--Except as otherwise expressly 
provided, whenever in this Act an amendment or repeal is expressed in 
terms of an amendment to, or repeal of, a section or other provision, 
the reference shall be considered to be made to a section or other 
provision of the National Narcotics Leadership Act of 1988 (21 U.S.C. 
1501 et seq.).</DELETED>

<DELETED>SEC. 2. DEPUTY DIRECTORS.</DELETED>

<DELETED>    (a) Establishment.--Section 1002 (21 U.S.C. 1501) is 
amended--</DELETED>
        <DELETED>    (1) in subsection (b)--</DELETED>
                <DELETED>    (A) by amending paragraph (2) to read as 
                follows:</DELETED>
<DELETED>    ``(2) There shall be in the Office of National Drug 
Control Policy a Deputy Director of the Office of National Drug Control 
Policy, a Deputy Director for Demand Reduction, a Deputy Director for 
Supply Reduction, a Deputy Director for State and Local Affairs, and a 
Deputy Director of Intelligence.''; and</DELETED>
                <DELETED>    (B) by amending paragraph (3) to read as 
                follows:</DELETED>
<DELETED>    ``(3) The Deputy Director of the Office of National Drug 
Control Policy, the Deputy Director for Demand Reduction, the Deputy 
Director for Supply Reduction, the Deputy Director for State and Local 
Affairs, and the Deputy Director of Intelligence shall assist the 
Director in carrying out the responsibilities of the Director under 
this Act.''; and</DELETED>
        <DELETED>    (2) by amending subsection (c)(2) to read as 
        follows:</DELETED>
<DELETED>    ``(2) The Deputy Director for State and Local Affairs 
shall be the head of the Bureau of State and Local 
Affairs.''.</DELETED>
<DELETED>    (b) Appointment.--</DELETED>
        <DELETED>    (1) In general.--Section 1003(a) (21 U.S.C. 
        1502(a)) is amended--</DELETED>
                <DELETED>    (A) in each of paragraphs (1) and (2), by 
                inserting ``the Deputy Director of the Office of 
                National Drug Control Policy,' after ``The 
                Director,'';</DELETED>
                <DELETED>    (B) in each of paragraphs (1) and (2), by 
                striking ``and the Associate Director for National Drug 
                Control Policy'' and inserting ``the Deputy Director 
                for State and Local Affairs, and the Deputy Director of 
                Intelligence''; and</DELETED>
                <DELETED>    (C) in paragraph (2), by striking ``, a 
                Deputy Director, or Associate Director'' and inserting 
                ``or as a Deputy Director''.</DELETED>
        <DELETED>    (2) Deadline for nomination.--The President shall 
        submit to the Senate nominations of individuals for appointment 
        as the Deputy Director of the Office of National Drug Control 
        Policy, the Deputy Director for Demand Reduction, the Deputy 
        Director for Supply Reduction, the Deputy Director for State 
        and Local Affairs, and the Deputy Director of Intelligence of 
        the Office of National Drug Control Policy by not later than 90 
        days after the date of the enactment of this Act.</DELETED>
        <DELETED>    (3) Continued service of associate director.--The 
        individual serving on the date of the enactment of this Act as 
        Associate Director for National Drug Control Policy may act as 
        the Deputy Director for State and Local Affairs until such time 
        as an individual is appointed to that position in accordance 
        with the amendments made by this Act.</DELETED>
        <DELETED>    (4) Clerical amendment.--The heading of section 
        1003 (21 U.S.C. 1502) is amended to read as follows:</DELETED>

<DELETED>``SEC. 1003. APPOINTMENT AND DUTIES OF DIRECTOR AND DEPUTY 
              DIRECTORS.''.</DELETED>

<DELETED>    (c) Compensation.--</DELETED>
        <DELETED>    (1) In general.--Chapter 53 of title 5, United 
        States Code, is amended--</DELETED>
                <DELETED>    (A) in section 5314, by inserting after 
                the item relating to the Deputy Director for Supply 
                Reduction, Office of National Drug Control Policy, the 
                following:</DELETED>
        <DELETED>    ``Deputy Director for State and Local Affairs, 
        Office of National Drug Control Policy.</DELETED>
        <DELETED>    ``Deputy Director of Intelligence, Office of 
        National Drug Control Policy.'';</DELETED>
                <DELETED>    (B) in section 5313, by adding at the end 
                the following:</DELETED>
        <DELETED>    ``Deputy Director of the Office of National Drug 
        Control Policy.''; and</DELETED>
                <DELETED>    (C) in section 5315, by striking the item 
                relating to the Associate Director for National Drug 
                Control Policy, Office of National Drug Control 
                Policy.</DELETED>
        <DELETED>    (2) Clerical amendment.--Section 1003(a) (21 
        U.S.C. 1502(a)) is amended by striking paragraph 
        (4)(C).</DELETED>

<DELETED>SEC. 3. EXPANSION OF RESPONSIBILITIES OF DIRECTOR.</DELETED>

<DELETED>    (a) Expansion of Responsibilities.--Section 1003(b) (21 
U.S.C. 1502(b)) is amended--</DELETED>
        <DELETED>    (1) by amending paragraph (1) to read as 
        follows:</DELETED>
        <DELETED>    ``(1) establish Federal policies, objectives, 
        goals, priorities, and performance measures (including specific 
        annual agency targets expressed in terms of precise 
        percentages) for the National Drug Control Program and for each 
        National Drug Control Program agency, which include targets for 
        the following:</DELETED>
                <DELETED>    ``(A) reduction of unlawful drug use to 3 
                percent of the population of the United States or less 
                by December 31, 2001 (as measured in terms of overall 
                illicit drug use during the past 30 days by the 
                National Household Survey), and achievement of at least 
                25 percent of such reduction during each of 1998, 1999, 
                2000, and 2001;</DELETED>
                <DELETED>    ``(B) reduction of adolescent unlawful 
                drug use (as measured in terms of illicit drug use 
                during the past 30 days by the Monitoring the Future 
                Survey of the University of Michigan or the National 
                PRIDE Survey conducted by the National Parents' 
                Resource Institute for Drug Education) to 3 percent of 
                the adolescent population of the United States or less 
                by December 31, 2001, and achievement of at least 25 
                percent of such reduction during each of 1998, 1999, 
                2000, and 2001;</DELETED>
                <DELETED>    ``(C) reduction of the availability of 
                cocaine, heroin, marijuana, and methamphetamine in the 
                United States by 80 percent by December 31, 
                2001;</DELETED>
                <DELETED>    ``(D) reduction of the respective 
                nationwide average street purity levels for cocaine, 
                heroin, marijuana, and methamphetamine (as estimated by 
                the interagency drug flows assessment led by the Office 
                of National Drug Control Policy, and based on 
                statistics collected by the Drug Enforcement 
                Administration and other National Drug Control Program 
                agencies identified as relevant by the Director) by 60 
                percent by December 31, 2001, and achievement of at 
                least 25 percent of each such reduction during each of 
                1998, 1999, 2000, and 2001;</DELETED>
                <DELETED>    ``(E) reduction of drug-related crime in 
                the United States by 50 percent by December 31, 2001, 
                and achievement of at least 25 percent of such 
                reduction during each of 1998, 1999, 2000, and 2001, 
                including--</DELETED>
                        <DELETED>    ``(i) reduction of State and 
                        Federal unlawful drug trafficking and 
                        distribution;</DELETED>
                        <DELETED>    ``(ii) reduction of State and 
                        Federal crimes committed by persons under the 
                        influence of unlawful drugs; and</DELETED>
                        <DELETED>    ``(iii) reduction of State and 
                        Federal crimes committed for the purpose of 
                        obtaining unlawful drugs or obtaining property 
                        that is intended to be used for the purchase of 
                        unlawful drugs; and</DELETED>
                <DELETED>    ``(F) reduction of drug-related emergency 
                room incidents in the United States (as measured by 
                data of the Drug Abuse Warning Network on illicit drug 
                abuse), including incidents involving gunshot wounds 
                and automobile accidents in which illicit drugs are 
                identified in the bloodstream of the victim, by 50 
                percent by December 31, 2001;'';</DELETED>
        <DELETED>    (2) by amending paragraph (3) to read as 
        follows:</DELETED>
        <DELETED>    ``(3) coordinate, oversee, and evaluate the 
        effectiveness of the implementation of the policies, 
        objectives, goals, performance measures, and priorities 
        established under paragraph (1) and the fulfillment of the 
        responsibilities of the National Drug Control Program agencies 
        under the National Drug Control Strategy;'';</DELETED>
        <DELETED>    (3) in paragraph (5), by inserting ``and 
        nongovernmental entities involved in demand reduction'' after 
        ``governments'';</DELETED>
        <DELETED>    (4) by striking ``and'' at the end of paragraph 
        (7);</DELETED>
        <DELETED>    (5) by striking the period at the end of paragraph 
        (8) and inserting a semicolon; and</DELETED>
        <DELETED>    (6) by adding at the end the following new 
        paragraphs:</DELETED>
        <DELETED>    ``(9) require each National Drug Control Program 
        agency to submit to the Director on a semi-annual basis 
        (beginning with the first 6 months of 1998) an evaluation of 
        progress by the agency with respect to drug control program 
        goals using the performance measures referred to in paragraph 
        (1), including progress with respect to--</DELETED>
                <DELETED>    ``(A) success in reducing domestic and 
                foreign sources of illegal drugs;</DELETED>
                <DELETED>    ``(B) success in protecting the borders of 
                the United States (and in particular the Southwestern 
                border of the United States) from penetration by 
                illegal narcotics;</DELETED>
                <DELETED>    ``(C) success in reducing violent crime 
                associated with drug use in the United 
                States;</DELETED>
                <DELETED>    ``(D) success in reducing the negative 
                health and social consequences of drug use in the 
                United States; and</DELETED>
                <DELETED>    ``(E) implementation of drug treatment and 
                prevention programs in the United States and 
                improvements in the adequacy and effectiveness of such 
                programs;</DELETED>
        <DELETED>    ``(10) submit to Congress on a semi-annual basis, 
        not later than 60 days after the date of the last day of the 
        applicable 6-month period, a summary of--</DELETED>
                <DELETED>    ``(A) each of the evaluations received by 
                the Director under paragraph (9); and</DELETED>
                <DELETED>    ``(B) the progress of each National Drug 
                Control Program agency toward the drug control program 
                goals of the agency using the performance measures 
                described in paragraph (1);</DELETED>
        <DELETED>    ``(11) require the National Drug Control Program 
        agencies to submit to the Director not later than February 1 of 
        each year a detailed accounting of all funds expended by the 
        agencies for National Drug Control Program activities during 
        the previous fiscal year, and require such accounting to be 
        authenticated by the Inspector General for each agency prior to 
        submission to the Director;</DELETED>
        <DELETED>    ``(12) submit to Congress not later than April 1 
        of each year the information submitted to the Director under 
        paragraph (11);</DELETED>
        <DELETED>    ``(13) submit to Congress not later than August 1 
        of each year a report including--</DELETED>
                <DELETED>    ``(A) the budget guidance provided by the 
                Director to each National Drug Control Program agency 
                for the fiscal year in which the report is submitted 
                and for the other fiscal years within the applicable 
                five-year budget plan relating to such fiscal year; 
                and</DELETED>
                <DELETED>    ``(B) a summary of the request of each 
                National Drug Control Program agency to the Director 
                under this Act (prior to review of the request by the 
                Office of Management and Budget) for the resources 
                required to achieve the targets of the agency under 
                this Act;</DELETED>
        <DELETED>    ``(14) act as a representative of the President 
        before Congress on all aspects of the National Drug Control 
        Program;</DELETED>
        <DELETED>    ``(15) act as the primary spokesperson of the 
        President on drug issues;</DELETED>
        <DELETED>    ``(16) make recommendations to National Drug 
        Control Program agency heads with respect to implementation of 
        Federal counter-drug programs;</DELETED>
        <DELETED>    ``(17) take such actions as necessary to oppose 
        any attempt to legalize the use of a substance (in any form) 
        that--</DELETED>
                <DELETED>    ``(A) is listed in schedule I of section 
                202 of the Controlled Substances Act (21 U.S.C. 812); 
                and</DELETED>
                <DELETED>    ``(B) has not been approved for use for 
                medical purposes by the Food and Drug Administration; 
                and</DELETED>
        <DELETED>    ``(18) ensure that drug prevention and drug 
        treatment research and information is effectively disseminated 
        by National Drug Control Program agencies to State and local 
        governments and nongovernmental entities involved in demand 
        reduction by--</DELETED>
                <DELETED>    ``(A) encouraging formal consultation 
                between any such agency that conducts or sponsors 
                research, and any such agency that disseminates 
                information in developing research and information 
                product development agendas;</DELETED>
                <DELETED>    ``(B) encouraging such agencies (as 
                appropriate) to develop and implement dissemination 
                plans that specifically target State and local 
                governments and nongovernmental entities involved in 
                demand reduction; and</DELETED>
                <DELETED>    ``(C) developing a single interagency 
                clearinghouse for the dissemination of research and 
                information by such agencies to State and local 
                governments and nongovernmental agencies involved in 
                demand reduction.''.</DELETED>
<DELETED>    (b) Survey of Drug Use.--(1) The University of Michigan 
shall not be prohibited under any law from conducting the survey of 
drug use among young people in the United States known as the 
Monitoring the Future Survey.</DELETED>
<DELETED>    (2) The National Parents' Resource Institute for Drug 
Education in Atlanta, Georgia, shall not be prohibited under any law 
from conducting the survey of drug use among young people in the United 
States known as the National PRIDE Survey.</DELETED>

<DELETED>SEC. 4. EXPANSION OF POWERS OF DIRECTOR.</DELETED>

<DELETED>    Section 1003(d) (21 U.S.C. 1502(d)) is amended--</DELETED>
        <DELETED>    (1) in paragraph (9), by striking the period and 
        inserting a semicolon; and</DELETED>
        <DELETED>    (2) by adding at the end the following new 
        paragraphs:</DELETED>
        <DELETED>    ``(10) require the heads of National Drug Control 
        Program agencies to provide the Director with statistics, 
        studies, reports, and any other information regarding Federal 
        control of drug abuse;</DELETED>
        <DELETED>    ``(11) require the heads of National Drug Control 
        Program agencies to provide the Director with information 
        regarding any position (before an individual is nominated for 
        such position) that--</DELETED>
                <DELETED>    ``(A) relates to the National Drug Control 
                Program;</DELETED>
                <DELETED>    ``(B) is at or above the level of Deputy 
                Assistant Secretary; and</DELETED>
                <DELETED>    ``(C) involves responsibility for Federal 
                counternarcotics or anti-drug programs; and</DELETED>
        <DELETED>    ``(12) make recommendations to the National Drug 
        Intelligence Center on the specific projects that the Director 
        determines will enhance the effectiveness of implementation of 
        the National Drug Control Strategy.''.</DELETED>

<DELETED>SEC. 5. SUBMISSION OF NATIONAL DRUG CONTROL 
              STRATEGY.</DELETED>

<DELETED>    (a) In General.--Section 1005(a) is amended--</DELETED>
        <DELETED>    (1) by amending paragraph (2)(A) to read as 
        follows:</DELETED>
        <DELETED>    ``(A) include comprehensive, research-based, 
        specific, long-range goals and performance measures (including 
        specific annual targets expressed in terms of precise 
        percentages) for reducing drug abuse and the consequences of 
        drug abuse in the United States;'';</DELETED>
        <DELETED>    (2) by striking ``and'' at the end of paragraph 
        (2)(C);</DELETED>
        <DELETED>    (3) by striking paragraph (2)(D);</DELETED>
        <DELETED>    (4) by adding at the end of paragraph (2) the 
        following new paragraphs:</DELETED>
        <DELETED>    ``(D) include 4-year projections for National Drug 
        Control Program priorities (including budget priorities); 
        and</DELETED>
        <DELETED>    ``(E) review international, Federal, State, local, 
        and private sector drug control activities to ensure that the 
        United States pursues well-coordinated and effective drug 
        control at all levels of government.'';</DELETED>
        <DELETED>    (5) in paragraph (3)(A), by striking clauses (iv) 
        and (v) and inserting the following:</DELETED>
        <DELETED>    ``(iv) private citizens and organizations with 
        experience and expertise in demand reduction;</DELETED>
        <DELETED>    ``(v) private citizens and organizations with 
        experience and expertise in supply reduction; and</DELETED>
        <DELETED>    ``(vi) appropriate representatives of foreign 
        governments.'';</DELETED>
        <DELETED>    (6) in paragraph (4)--</DELETED>
                <DELETED>    (A) in subparagraph (B), by amending 
                clauses (i) through (vi) to read as follows:</DELETED>
                <DELETED>    ``(i) the quantities of cocaine, heroin, 
                marijuana, methamphetamine, ecstasy, and rohypnol 
                available for consumption in the United 
                States;</DELETED>
                <DELETED>    ``(ii) the amount of cocaine, heroin, 
                marijuana, ecstasy, rohypnol, methamphetamine, and 
                precursor chemicals entering the United 
                States;</DELETED>
                <DELETED>    ``(iii) the number of hectares of 
                marijuana, poppy, and coca cultivated and destroyed 
                domestically and in other countries;</DELETED>
                <DELETED>    ``(iv) the number of metric tons of 
                marijuana, cocaine, heroin, and methamphetamine 
                seized;</DELETED>
                <DELETED>    ``(v) the number of cocaine and 
                methamphetamine processing labs destroyed domestically 
                and in other countries;</DELETED>
                <DELETED>    ``(vi) changes in the price and purity of 
                heroin and cocaine, changes in price of 
                methamphetamine, and changes in tetrahydrocannabinol 
                level of marijuana;'';</DELETED>
                <DELETED>    (B) by striking ``and'' at the end of 
                subparagraph (C);</DELETED>
                <DELETED>    (C) by striking the period at the end 
                subparagraph (D) and inserting ``; and''; and</DELETED>
                <DELETED>    (D) by adding at the end the following new 
                subparagraph:</DELETED>
        <DELETED>    ``(E) assessment of the cultivation of illegal 
        drugs in the United States.''; and</DELETED>
        <DELETED>    (7) in paragraph (5)--</DELETED>
                <DELETED>    (A) in the matter preceding subparagraph 
                (A), by striking ``February 1, 1995'' and inserting 
                ``February 1, 1998'';</DELETED>
                <DELETED>    (B) in the matter preceding subparagraph 
                (A), by striking ``second'';</DELETED>
                <DELETED>    (C) by striking ``and'' at the end of 
                subparagraph (C);</DELETED>
                <DELETED>    (D) by striking the period at the end of 
                subparagraph (D) and inserting ``; and''; and</DELETED>
                <DELETED>    (E) by adding at the end the following new 
                subparagraph:</DELETED>
        <DELETED>    ``(E) a description of the National Drug Control 
        Program performance measures described in subsection 
        (a)(2)(A).''.</DELETED>
<DELETED>    (b) Goals and Performance Measures for National Drug 
Control Strategy.--Section 1005(b) is amended--</DELETED>
        <DELETED>    (1) in the heading, by striking ``, Objectives, 
        and Priorities'' and inserting ``and Performance 
        Measures'';</DELETED>
        <DELETED>    (2) in the matter after the heading, by inserting 
        ``(1)'' before ``Each National Drug Control 
        Strategy'';</DELETED>
        <DELETED>    (3) by redesignating paragraphs (1) through (6) as 
        subparagraphs (A) through (F);</DELETED>
        <DELETED>    (4) in subparagraph (A) (as redesignated by 
        paragraph (3)), by striking ``and priorities'' and inserting 
        ``and performance measures'';</DELETED>
        <DELETED>    (5) in subparagraph (C) (as redesignated by 
        paragraph (3)), by striking ``3-year projections'' and 
        inserting ``4-year projections''; and</DELETED>
        <DELETED>    (6) by adding at the end the following new 
        paragraph:</DELETED>
<DELETED>    ``(2) In establishing the performance measures required by 
this subsection, the Director shall--</DELETED>
        <DELETED>    ``(A) establish performance measures and targets 
        expressed in terms of precise percentages for each National 
        Drug Control Strategy goal and objective;</DELETED>
        <DELETED>    ``(B) revise such performance measures and targets 
        as necessary, and reflect such performance measures and targets 
        in the National Drug Control Program budget submitted to 
        Congress;</DELETED>
        <DELETED>    ``(C) consult with affected National Drug Control 
        Program agencies;</DELETED>
        <DELETED>    ``(D) identify programs and activities of National 
        Drug Control Program agencies that support the goals of the 
        National Drug Control Strategy;</DELETED>
        <DELETED>    ``(E) evaluate in detail the implementation by 
        each National Drug Control Program agency of program activities 
        supporting the National Drug Control Strategy;</DELETED>
        <DELETED>    ``(F) monitor consistency between the drug-related 
        goals of the National Drug Control Program agencies and ensure 
        that drug control agency goals and budgets fully support, and 
        are fully consistent with, the National Drug Control 
        Strategy;</DELETED>
        <DELETED>    ``(G) coordinate the development and 
        implementation of national drug control data collection and 
        reporting systems to support Federal policy formulation and 
        performance measurement;</DELETED>
        <DELETED>    ``(H) ensure that no Federal drug control funds 
        are expended for any study or contract relating to the 
        legalization (for a medical use or any other use) of a 
        substance listed in schedule I of section 202 of the Controlled 
        Substances Act (21 U.S.C. 812); and</DELETED>
        <DELETED>    ``(I) ensure that no Federal funds appropriated 
        for the High Intensity Drug Trafficking Program are expended 
        for the expansion of drug treatment programs.''.</DELETED>

<DELETED>SEC. 6. REPORT ON DESIGNATION OF HIGH INTENSITY DRUG 
              TRAFFICKING AREAS.</DELETED>

<DELETED>    Section 1005(c)(3) is amended to read as 
follows:</DELETED>
<DELETED>    ``(3) Not later than March 1 of each year, the Director 
shall submit to Congress a report--</DELETED>
        <DELETED>    ``(A) on the effectiveness of, and need for, the 
        designation of areas under this subsection as high intensity 
        drug trafficking areas; and</DELETED>
        <DELETED>    ``(B) that includes any recommendations of the 
        Director for legislative action with respect to such 
        designation.''.</DELETED>

<DELETED>SEC. 7. REPROGRAMMING AND TRANSFER OF FUNDS.</DELETED>

<DELETED>    (a) Expansion of Transfer Authority.--Section 1003(d)(8) 
(21 U.S.C. 1502(d)(8)) is amended to read as follows:</DELETED>
        <DELETED>    ``(8) except to the extent that the Director's 
        authority under this paragraph is limited in an annual 
        appropriations Act, and with the concurrence of the head of the 
        affected agency and upon advance approval of the Committees on 
        Appropriations and the authorizing committees of the House of 
        Representatives and the Senate, transfer funds appropriated to 
        a National Drug Control Program agency program, activity, or 
        function designated by the Director pursuant to subsection (c) 
        to a different National Drug Control Program agency program, 
        activity, or function designated by the Director pursuant to 
        such subsection in an amount that does not exceed 5 percent of 
        the amount appropriated to either program, activity, or 
        function;''.</DELETED>
<DELETED>    (b) Report.--Section 1003(c)(7) (21 U.S.C. 1502(c)(7)) is 
amended to read as follows:</DELETED>
<DELETED>    ``(7)(A) The Director shall report to Congress on a 
quarterly basis (beginning with the first quarter of 1998) on--
</DELETED>
        <DELETED>    ``(i) the need for any reprogramming or transfer 
        of funds appropriated for National Drug Control Program 
        activities; and</DELETED>
        <DELETED>    ``(ii) any funds appropriated for National Drug 
        Control Program activities that were reprogrammed or 
        transferred during the quarter covered by the report.</DELETED>
<DELETED>    ``(B) The Director shall report to Congress as required by 
paragraph (A) not later than 30 days after the last day of each 
applicable quarter.''.</DELETED>

<DELETED>SEC. 8. LONG-TERM PLAN FOR REDUCTION OF DRUG USE.</DELETED>

<DELETED>    Section 1003 (21 U.S.C. 1502) is amended by adding at the 
end the following new subsection:</DELETED>
<DELETED>    ``(g) Long-Term Plan for Reduction of Drug Use.--Not later 
than March 1, 1998, the Director shall submit to Congress a long-term 
plan for reducing the population of illegal drug users in the United 
States by December 31, 2001, to 3 percent of the population of the 
United States or less. Such plan shall include--</DELETED>
        <DELETED>    ``(1) a request for funds and other resources 
        necessary to achieve such reduction within the guidelines of 
        the balanced budget agreement of 1997; and</DELETED>
        <DELETED>    ``(2) the justifications for each such 
        request.''.</DELETED>

<DELETED>SEC. 9. DRUG POLICY COUNCIL.</DELETED>

<DELETED>    The National Narcotics Leadership Act of 1988 (21 U.S.C. 
1501 et seq.) is further amended by adding at the end of chapter 1 the 
following new section:</DELETED>

<DELETED>``SEC. 1013. DRUG POLICY COUNCIL.</DELETED>

<DELETED>    ``(a) Establishment.--There is established in the 
Executive Office of the President a Drug Policy Council, which shall be 
composed of the members of the President's cabinet, and the purpose of 
which shall be to make cabinet-level decisions regarding national drug 
policy.</DELETED>
<DELETED>    ``(b) Chairman.--The President shall be the Chairman of 
the Drug Policy Council established by subsection (a).</DELETED>
<DELETED>    ``(c) Executive Director.--The Director of the Office of 
National Drug Control Policy shall be the Executive Director of the 
Drug Policy Council established by subsection (a).''.</DELETED>

<DELETED>SEC. 10. DEFINITION OF NATIONAL DRUG CONTROL PROGRAM 
              AGENCY.</DELETED>

<DELETED>    Section 1010(6) (21 U.S.C. 1507(6)) is amended to read as 
follows:</DELETED>
        <DELETED>    ``(6) the term `National Drug Control Program 
        agency' means any agency that is responsible for implementing 
        any aspect of the National Drug Control Strategy, including any 
        agency that receives Federal funds to implement any aspect of 
        the National Drug Control Strategy;''.</DELETED>

<DELETED>SEC. 11. EXTENSION OF DATE FOR TERMINATION OF OFFICE OF 
              NATIONAL DRUG CONTROL POLICY.</DELETED>

<DELETED>    Section 1009 is amended by striking ``September 30, 1997'' 
and inserting ``September 30, 1999''.</DELETED>

<DELETED>SEC. 12. EXTENSION OF AUTHORIZATION OF 
              APPROPRIATIONS.</DELETED>

<DELETED>    Section 1011 is amended by striking ``8 succeeding fiscal 
years'' and inserting ``10 succeeding fiscal years''.</DELETED>

<DELETED>SEC. 13. REPORT REQUIRED.</DELETED>

<DELETED>    Not later than November 1, 1997, the Director of the 
Office of National Drug Control Policy shall submit to Congress a 
report including--</DELETED>
        <DELETED>    (1) proposed goals, targets, performance measures 
        (as described in section 1003(b)(1) of the National Narcotics 
        Leadership Act of 1998 (21 U.S.C. 1502(b)(1)), and specific 
        initiatives with respect to the National Drug Control Program, 
        including the High Intensity Drug Trafficking Area Program; 
        and</DELETED>
        <DELETED>    (2) proposals to coordinate the efforts of all 
        National Drug Control Program agencies.</DELETED>

<DELETED>SEC. 14. APPOINTMENT OF TEMPORARY ADMINISTRATOR FOR DRUG-FREE 
              COMMUNITIES SUPPORT PROGRAM.</DELETED>

<DELETED>    (a) In General.--Section 1031(c) (21 U.S.C. 1531(c)) is 
amended--</DELETED>
        <DELETED>    (1) by inserting ``(1)'' after ``(c) 
        Administration.--''; and</DELETED>
        <DELETED>    (2) by adding at the end the following new 
        paragraph:</DELETED>
<DELETED>    ``(2) The Director shall appoint an individual to act as 
Administrator until such time as an individual is appointed to such 
position under paragraph (1).''.</DELETED>
<DELETED>    (b) Deadline for Appointment.--The Director of the Office 
of National Drug Control Policy shall appoint an individual to act as 
Administrator of the Drug-Free Communities Support Program under 
section 1031(c)(2) of the National Narcotics Leadership Act of 1988 (as 
added by subsection (a)) not later than 30 days after the date of the 
enactment of this Act.</DELETED>

<DELETED>SEC. 15. CONSISTENCY WITH NATIONAL SECURITY ACT OF 
              1947.</DELETED>

<DELETED>    Section 1004 (21 U.S.C. 1503) is amended--</DELETED>
        <DELETED>    (1) in subsection (a)--</DELETED>
                <DELETED>    (A) by striking ``(1)'';</DELETED>
                <DELETED>    (B) by striking ``(2)(A)'' and inserting 
                ``(b) Consistency With National Security Act of 1947.--
                (1)'';</DELETED>
                <DELETED>    (C) by striking ``(B)'' and inserting 
                ``(2)''; and</DELETED>
                <DELETED>    (D) by striking ``subparagraph (A)'' and 
                inserting ``paragraph (1)''; and</DELETED>
        <DELETED>    (2) by redesignating subsections (b) and (c) as 
        subsections (c) and (d) respectively.</DELETED>

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Office of National Drug Control 
Policy Reauthorization Act of 1997''.

SEC. 2. REAUTHORIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY.

    (a) Definitions.--The National Narcotics Leadership Act of 1988 (21 
U.S.C. 1501 et seq.) is amended by inserting after section 1001 the 
following:

``SEC. 1001A. DEFINITIONS.

    ``In this subtitle:
            ``(1) Demand reduction.--The term `demand reduction' means 
        any activity conducted by a National Drug Control Program 
        agency, other than an enforcement activity, that is intended to 
        reduce the use of drugs, including--
                    ``(A) drug abuse education;
                    ``(B) drug abuse prevention;
                    ``(C) drug abuse treatment;
                    ``(D) drug abuse research;
                    ``(E) drug abuse rehabilitation;
                    ``(F) drug-free workplace programs; and
                    ``(G) drug testing.
            ``(2) Director.--The term `Director' means the Director of 
        National Drug Control Policy.
            ``(3) Drug.--The term `drug' has the meaning given the term 
        `controlled substance' in section 102(6) of the Controlled 
        Substances Act (21 U.S.C. 802(6)).
            ``(4) Drug control.--The term `drug control' means any 
        activity conducted by a National Drug Control Program agency 
        involving supply reduction or demand reduction, including any 
        activity to reduce the use of tobacco or alcoholic beverages by 
        underage individuals.
            ``(5) Fund.--The term `Fund' means the fund established 
        under section 1002(d).
            ``(6) National drug control program.--The term `National 
        Drug Control Program' means programs, policies, and activities 
        undertaken by National Drug Control Program agencies pursuant 
        to the responsibilities of such agencies under the National 
        Drug Control Strategy.
            ``(7) National drug control program agency.--The term 
        `National Drug Control Program agency' means any department or 
        agency and all dedicated units thereof, with responsibilities 
        under the National Drug Control Strategy, as designated jointly 
        by the Director and the President.
            ``(8) National drug control strategy.--The terms `National 
        Drug Control Strategy' and `Strategy' mean the strategy 
        developed and submitted to Congress under section 1005.
            ``(9) Office.--Unless the context clearly implicates 
        otherwise, the term `Office' means the Office of National Drug 
        Control Policy established under section 1002(a).
            ``(10) State and local affairs.--The term `State and local 
        affairs' means domestic activities conducted by a National Drug 
        Control Program agency that are intended to reduce the 
        availability and use of drugs, including--
                    ``(A) coordination and facilitation of Federal, 
                State, and local law enforcement drug control efforts;
                    ``(B) promotion of coordination and cooperation 
                among the drug supply reduction and demand reduction 
                agencies of the various States, territories, and units 
                of local government; and
                    ``(C) such other cooperative governmental 
                activities which promote a comprehensive approach to 
                drug control at the national, State, territory, and 
                local levels.
            ``(11) Supply reduction.--The term `supply reduction' means 
        any activity of a program conducted by a National Drug Control 
        Program agency that is intended to reduce the availability or 
use of drugs in the United States and abroad, including--
                    ``(A) international drug control;
                    ``(B) foreign and domestic drug intelligence;
                    ``(C) interdiction; and
                    ``(D) domestic drug law enforcement, including law 
                enforcement directed at drug users.''.
    (b) Establishment of Office of National Drug Control Policy.--
Section 1002 of the National Narcotics Leadership Act of 1988 (21 
U.S.C. 1501) is amended--
            (1) by striking subsections (a) and (b) and inserting the 
        following:
    ``(a) Establishment of Office.--There is established in the 
Executive Office of the President an Office of National Drug Control 
Policy, which shall--
            ``(1) develop national drug control policy;
            ``(2) coordinate and oversee the implementation of that 
        national drug control policy;
            ``(3) assess and certify the adequacy of national drug 
        control programs and the budget for those programs; and
            ``(4) evaluate the effectiveness of the national drug 
        control programs.
    ``(b) Director and Deputy Directors.--
            ``(1) Director.--There shall be at the head of the Office a 
        Director of National Drug Control Policy.
            ``(2) Deputy director of national drug control policy.--
        There shall be in the Office a Deputy Director of National Drug 
        Control Policy, who shall assist the Director in carrying out 
        the responsibilities of the Director under this Act.
            ``(3) Other deputy directors.--There shall be in the 
        Office--
                    ``(A) a Deputy Director for Demand Reduction, who 
                shall be responsible for the activities described in 
                subparagraphs (A) through (G) of section 1001A(1);
                    ``(B) a Deputy Director for Supply Reduction, who 
                shall be responsible for the activities described in 
                subparagraphs (A) through (C) of section 1001A(11); and
                    ``(C) a Deputy Director for State and Local 
                Affairs, who shall be responsible for the activities 
                described in subparagraphs (A) through (C) of section 
                1001A(10).'';
            (2) by striking subsection (c) and redesignating subsection 
        (d) as subsection (c); and
            (3) by adding at the end the following:
    ``(d) Office of National Drug Control Policy Gift Fund.--
            ``(1) Establishment.--There is established in the Treasury 
        a Fund for the receipt of gifts, both real and personal, for 
        the purpose of aiding or facilitating the work of the Office 
        under section 1003(c).
            ``(2) Contributions.--The Office may accept, hold, and 
        administer contributions to the Fund.
            ``(3) Use of amounts deposited.--Amounts deposited in the 
        Fund are authorized to be appropriated, to remain available 
        until expended for authorized purposes at the discretion of the 
        Director.''.
    (c) Appointment and Duties of Director and Deputy Directors.--
Section 1003 of the National Narcotics Leadership Act of 1988 (21 
U.S.C. 1502) is amended to read as follows:

``SEC. 1003. APPOINTMENT AND DUTIES OF DIRECTOR AND DEPUTY DIRECTORS.

    ``(a) Appointment.--
            ``(1) In general.--The Director, the Deputy Director of 
        National Drug Control Policy, the Deputy Director for Demand 
        Reduction, the Deputy Director for Supply Reduction, and the 
        Deputy Director for State and Local Affairs, shall each be 
        appointed by the President, by and with the advice and consent 
        of the Senate, and shall serve at the pleasure of the 
        President. In appointing the Deputy Director for Demand 
        Reduction under this paragraph, the President shall take into 
        consideration the scientific, educational or professional 
        background of the individual, and whether the individual has 
        experience in the fields of substance abuse prevention, 
        education, or treatment.
            ``(2) Duties of deputy director of national drug control 
        policy.--The Deputy Director of National Drug Control Policy 
        shall--
                    ``(A) carry out the duties and powers prescribed by 
                the Director; and
                    ``(B) serve as the Director in the absence of the 
                Director or during any period in which the office of 
                the Director is vacant.
            ``(3) Designation of other officers.--In the absence of the 
        Deputy Director, or if the office of the Deputy Director is 
        vacant, the Director shall designate such other permanent 
        employee of the Office to serve as the Director, if the 
        Director is absent or unable to serve.
            ``(4) Prohibition.--No person shall serve as Director or a 
        Deputy Director while serving in any other position in the 
        Federal Government.
            ``(5) Prohibition on political campaigning.--Any officer or 
        employee of the Office who is appointed to that position by the 
        President, by and with the advice and consent of the Senate, 
        may not participate in Federal election campaign activities, 
        except that such official is not prohibited by this paragraph 
        from making contributions to individual candidates.
    ``(b) Responsibilities.--The Director shall--
            ``(1) establish policies, goals, objectives, and priorities 
        for the National Drug Control Program;
            ``(2) promulgate the National Drug Control Strategy and 
        each report under section 1005(b) in accordance with section 
        1005;
            ``(3) coordinate and oversee the implementation by the 
        National Drug Control Program agencies of the policies, goals, 
        objectives, and priorities established under paragraph (1) and 
        the fulfillment of the responsibilities of such agencies under 
        the National Drug Control Strategy;
            ``(4) make such recommendations to the President as the 
        Director determines are appropriate regarding changes in the 
        organization, management, and budgets of Federal departments 
        and agencies engaged in drug enforcement, and changes in the 
        allocation of personnel to and within such departments and 
        agencies, to implement the policies, goals, priorities, and 
        objectives established under paragraph (1) and the National 
        Drug Control Strategy;
            ``(5) consult with and assist State and local governments 
        with respect to the formulation and implementation of National 
        Drug Control Policy and their relations with the National Drug 
        Control Program agencies;
            ``(6) appear before duly constituted committees and 
        subcommittees of the House of Representatives and of the Senate 
        to represent the drug policies of the executive branch;
            ``(7) notify any National Drug Control Program agency if 
        its policies are not in compliance with the responsibilities of 
        such agency under the National Drug Control Strategy and 
        transmit a copy of each such notification to the President;
            ``(8) provide, by July 1 of each year, budget 
        recommendations to the heads of departments and agencies with 
        responsibilities under the National Drug Control Program, which 
        recommendations shall apply to next budget year scheduled for 
        formulation under the Budget and Accounting Act of 1921, and 
        each of the 4 subsequent fiscal years, and address funding 
        priorities developed in the National Drug Control Strategy;
            ``(9) serve as the representative of the President in 
        appearing before Congress on all issues relating to the 
        National Drug Control Program; and
            ``(10) serve as primary spokesperson of the Administration 
        on drug issues.
    ``(c) National Drug Control Program Budget.--
            ``(1) In general.--For each fiscal year, with the advice of 
        the program managers of departments and agencies with 
        responsibilities under the National Drug Control Program, the 
        Director shall--
                    ``(A) develop a consolidated National Drug Control 
                Program budget proposal to implement the National Drug 
                Control Strategy;
                    ``(B) submit the budget proposal to the President; 
                and
                    ``(C) after submission under subparagraph (B), 
                submit a copy of the budget proposal to Congress.
            ``(2) Responsibilities of national drug control program 
        agencies.--
                    ``(A) In general.--Each Federal Government program 
                manager, agency head, and department head with 
                responsibilities under the National Drug Control 
                Strategy shall transmit the drug control budget request 
                of the agency or department to the Director at the same 
                time as such request is submitted to their superiors 
                (and before submission to the Office of Management and 
                Budget) in the preparation of the budget of the 
                President submitted to Congress under section 1105(a) 
                of title 31, United States Code.
                    ``(B) Requests for specific initiatives.--The 
                Director shall request the head of a department or 
                agency to include in the budget submission of the 
                department or agency to the Office of Management and 
                Budget funding requests for specific initiatives that 
                are consistent with the priorities of the President for 
                the National Drug Control Strategy and certifications 
                made pursuant to paragraph (3), and the head of the 
                department or agency shall comply with such a request.
                    ``(C) Submission of drug control budget requests.--
                The head of each National Drug Control Program agency 
                shall ensure timely development and submission to the 
                Director of drug control budget requests transmitted 
                pursuant to this paragraph, in such format as may be 
                designated by the Director with the concurrence of the 
                Director of the Office of Management and Budget.
            ``(3) Certification.--The Director shall--
                    ``(A) review each drug control budget request 
                submitted to the Director under paragraph (2);
                    ``(B) certify in writing as to the adequacy of such 
                request in whole or in part to implement the objectives 
                of the National Drug Control Strategy for the year for 
                which the request is submitted and, with respect to a 
                request that is not certified as adequate to implement 
                the objectives of the National Drug Control Strategy, 
                include in the certification an initiative or funding 
                level that would make the request adequate;
                    ``(C) notify the program manager, agency head, or 
                department head, as applicable, regarding each 
                certification under subparagraph (B); and
                    ``(D) maintain a record of each certification under 
                subparagraph (B).
            ``(4) Reprogramming and transfer requests.--
                    ``(A) In general.--No National Drug Control Program 
                agency shall submit to Congress a reprogramming or 
                transfer request with respect to any amount of 
                appropriated funds in an amount exceeding $5,000,000 
                which is included in the National Drug Control Program 
                budget unless the request has been approved by the 
                Director.
                    ``(B) Appeal.--The head of any National Drug 
                Control Program agency may appeal to the President any 
                disapproval by the Director of a reprogramming or 
                transfer request under this paragraph.
                    ``(C) Report.--The Director shall annually submit 
                to Congress a report describing the approval of any 
                reprogramming or transfer of appropriated funds 
                pursuant to this paragraph.
    ``(d) Powers of the Director.--In carrying out subsection (b), the 
Director may--
            ``(1) select, appoint, employ, and fix compensation of such 
        officers and employees as may be necessary to carry out the 
        functions of the Office of National Drug Control Policy under 
        this title;
            ``(2) request the head of a department or agency or program 
        to place department, agency, or program personnel who are 
        engaged in drug control activities on temporary detail to 
        another department or agency in order to implement the National 
        Drug Control Strategy, and the head of the department or agency 
        shall comply with such a request;
            ``(3) use for administrative purposes, on a reimbursable 
        basis, the available services, equipment, personnel, and 
        facilities of Federal, State, and local agencies;
            ``(4) procure the services of experts and consultants in 
        accordance with section 3109 of title 5, United States Code, 
        relating to appointments in the Federal Service, at rates of 
        compensation for individuals not to exceed the daily equivalent 
        of the rate of pay payable under level IV of the Executive 
        Schedule under section 5311 of title 5, United States Code;
            ``(5) accept and use gifts and donations of property from 
        Federal, State, and local government agencies, and from the 
        private sector, as authorized in section 1002(d);
            ``(6) use the mails in the same manner as any other 
        department or agency of the executive branch;
            ``(7) monitor implementation of the National Drug Control 
        Program, including--
                    ``(A) conducting program and performance audits and 
                evaluations;
                    ``(B) requesting assistance from the Inspector 
                General of the relevant agency in such audits and 
                evaluations; and
                    ``(C) commissioning studies and reports by a 
                National Drug Control Program agency, with the 
                concurrence of the head of the affected agency;
            ``(8) except to the extent that the authority of the 
        Director under this paragraph is limited in an annual 
        appropriations Act, with the concurrence of the head of each 
        affected agency, and upon advance notice to the Committees of 
        Appropriations of the House of Representative and the Senate, 
        transfer funds appropriated to a National Drug Control Program 
        agency to a different National Drug Control Program agency, in 
        an amount that does not exceed 2 percent of the total amount 
        appropriated to the National Drug Control Program agency from 
which funds are transferred under this paragraph;
            ``(9) issue to the head of a National Drug Control Program 
        agency a fund control notice described in subsection (f) to 
        ensure compliance with the National Drug Control Program; and
            ``(10) participate in the drug certification process 
        pursuant to section 490 of the Foreign Assistance Act of 1961 
        (22 U.S.C. 2291j).
    ``(e) Personnel Detailed to Office.--
            ``(1) Evaluations.--Notwithstanding any provision of 
        chapter 43 of title 5, United States Code, the Director shall 
        perform the evaluation of the performance of any employee 
        detailed to the Office of National Drug Control Policy for 
        purposes of the applicable performance appraisal system 
        established under such chapter for any rating period, or part 
        thereof, that such employee is detailed to such office.
            ``(2) Compensation.--
                    ``(A) Bonus payments.--Notwithstanding any other 
                provision of law, the Director may provide periodic 
                bonus payments to any employee detailed to the Office 
                of National Drug Control Policy.
                    ``(B) Restrictions.--An amount paid under this 
                paragraph to an employee for any period--
                            ``(i) shall not be greater than 20 percent 
                        of the basic pay paid or payable to such 
                        employee for such period; and
                            ``(ii) shall be in addition to the basic 
                        pay of such employee.
                    ``(C) Aggregate amount.--The aggregate amount paid 
                during any fiscal year to an employee detailed to the 
                Office of National Drug Control Policy as basic pay, 
                awards, bonuses, and other compensation shall not 
                exceed the annual rate payable at the end of such 
                fiscal year for positions at level III of the Executive 
                Schedule.''.
    (d) Coordination With Executive Branch Departments and Agencies.--
Section 1004 of the National Narcotics Leadership Act of 1988 (21 
U.S.C. 1503) is amended--
            (1) by striking the section designation and the section 
        heading and inserting the following:

``SEC. 1004. COORDINATION WITH NATIONAL DRUG CONTROL PROGRAM AGENCIES 
              IN DEMAND REDUCTION, SUPPLY REDUCTION, AND STATE AND 
              LOCAL AFFAIRS.'';

            (2) in subsection (a)--
                    (A) by striking paragraph (1) and inserting the 
                following:
            ``(1) In general.--Upon the request of the Director, the 
        head of any National Drug Control Program agency shall 
        cooperate with and provide to the Director any statistics, 
        studies, reports, and other information of the agency 
        pertaining to--
                    ``(A) drug abuse control; or
                    ``(B) the manner in which amounts made available to 
                that agency for drug control are being used by that 
                agency.''; and
                    (B) by adding at the end the following:
            ``(3) Illegal drug cultivation.--The Secretary of 
        Agriculture shall annually submit to the Director an assessment 
        of the acreage of illegal drug cultivation in the United 
        States.''.
    (e) Development and Submission of National Drug Control Strategy.--
Section 1005 of the National Narcotics Leadership Act of 1988 (21 
U.S.C. 1504) is amended to read as follows:

``SEC. 1005. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, AND ASSESSMENT OF 
              NATIONAL DRUG CONTROL STRATEGY.

    ``(a) Timing, Contents, and Process for Development and Submission 
of National Drug Control Strategy.--
            ``(1) Timing.--Not later than February 1, 1997, the 
        President shall submit to Congress a National Drug Control 
        Strategy, which shall set forth a comprehensive plan, covering 
        a period of not more than 10 years, for reducing drug abuse and 
        the consequences of drug abuse in the United States, by 
        limiting the availability of and reducing the demand for 
        illegal drugs.
            ``(2) Contents.--
                    ``(A) In general.--The National Drug Control 
                Strategy submitted under paragraph (1) shall include--
                            ``(i) comprehensive, research-based, long-
                        range, quantifiable, goals for reducing drug 
                        abuse and the consequences of drug abuse in the 
                        United States;
                            ``(ii) short-term measurable objectives to 
                        accomplish long-term quantifiable goals that 
                        the Director determines may be realistically 
                        achieved during the 2-year period beginning on 
the date on which the strategy is submitted;
                            ``(iii) 5-year projections for program and 
                        budget priorities; and
                            ``(iv) a review of State, local, and 
                        private sector drug control activities to 
                        ensure that the United States pursues well-
                        coordinated and effective drug control at all 
                        levels of government.
                    ``(B) Classified information.--Any contents of the 
                National Drug Control Strategy that involves 
                information properly classified under criteria 
                established by an Executive order shall be presented to 
                Congress separately from the rest of the Strategy.
            ``(3) Process for development and submission.--
                    ``(A) Consultation.--In developing and effectively 
                implementing the National Drug Control Strategy, the 
                Director--
                            ``(i) shall consult with--
                                    ``(I) the heads of the National 
                                Drug Control Program agencies;
                                    ``(II) Congress;
                                    ``(III) State and local officials;
                                    ``(IV) private citizens and 
                                organizations with experience and 
                                expertise in demand reduction; and
                                    ``(V) private citizens and 
                                organizations with experience and 
                                expertise in supply reduction; and
                            ``(ii) may require the National Drug 
                        Intelligence Center and the El Paso 
                        Intelligence Center to undertake specific tasks 
                        or projects to implement the Strategy.
                    ``(B) Inclusion in strategy.--The National Drug 
                Control Strategy under this subsection, and each report 
                submitted under subsection (b), shall include a list of 
                each entity consulted under subparagraph (A)(i).
            ``(4) Modification and resubmittal.--Notwithstanding any 
        other provision of law, the Director may modify a National Drug 
        Control Strategy submitted under paragraph (1) at any time.
    ``(b) Annual Strategy Report.--
            ``(1) In general.--Not later than February 1, 1998, and on 
        February 1 of each year thereafter, the President shall submit 
        to Congress a report on the progress in implementing the 
        Strategy under subsection (a), which shall include--
                    ``(A) an assessment of the Federal effectiveness in 
                achieving the Strategy goals and objectives using the 
                performance measurement system described in subsection 
                (c), including--
                            ``(i) an assessment of drug use and 
                        availability in the United States; and
                            ``(ii) an estimate of the effectiveness of 
                        interdiction, treatment, prevention, law 
                        enforcement, and international programs under 
                        the National Drug Control Strategy in effect 
                        during the preceding year, or in effect as of 
                        the date on which the report is submitted;
                    ``(B) any modifications of the Strategy or the 
                performance measurement system described in subsection 
                (c);
                    ``(C) an assessment of how the budget proposal 
                submitted under section 1003(c) is intended to 
                implement the Strategy and whether the funding levels 
                contained in such proposal are sufficient to implement 
                such Strategy;
                    ``(D) beginning on February 1, 1999, and every 2 
                years thereafter, measurable data evaluating the 
                success or failure in achieving the short-term 
                measurable objectives described in subsection 
                (a)(2)(A)(ii);
                    ``(E) an assessment of current drug use (including 
                inhalants) and availability, impact of drug use, and 
                treatment availability, which assessment shall 
                include--
                            ``(i) estimates of drug prevalence and 
                        frequency of use as measured by national, 
                        State, and local surveys of illicit drug use 
                        and by other special studies of--
                                    ``(I) casual and chronic drug use;
                                    ``(II) high-risk populations, 
                                including school dropouts, the homeless 
                                and transient, arrestees, parolees, 
                                probationers, and juvenile delinquents; 
                                and
                                    ``(III) drug use in the workplace 
                                and the productivity lost by such use;
                            ``(ii) an assessment of the reduction of 
                        drug availability against an ascertained 
                        baseline, as measured by--
                                    ``(I) the quantities of cocaine, 
                                heroin, marijuana, methamphetamine, and 
                                other drugs available for consumption 
                                in the United States;
                                    ``(II) the amount of marijuana, 
                                cocaine, and heroin entering the United 
                                States;
                                    ``(III) the number of hectares of 
                                marijuana, poppy, and coca cultivated 
                                and destroyed;
                                    ``(IV) the number of metric tons of 
                                marijuana, heroin, and cocaine seized;
                                    ``(V) the number of cocaine and 
                                methamphetamine processing laboratories 
                                destroyed;
                                    ``(VI) changes in the price and 
                                purity of heroin and cocaine;
                                    ``(VII) the amount and type of 
                                controlled substances diverted from 
                                legitimate retail and wholesale 
                                sources; and
                                    ``(VIII) the effectiveness of 
                                Federal technology programs at 
                                improving drug detection capabilities 
                                in interdiction, and at United States 
                                ports of entry;
                            ``(iii) an assessment of the reduction of 
                        the consequences of drug use and availability, 
                        which shall include estimation of--
                                    ``(I) the burden drug users placed 
                                on hospital emergency departments in 
                                the United States, such as the quantity 
                                of drug-related services provided;
                                    ``(II) the annual national health 
                                care costs of drug use, including costs 
                                associated with people becoming 
                                infected with the human immuno- 
                                deficiency virus and other infectious 
                                diseases as a result of drug use;
                                    ``(III) the extent of drug-related 
                                crime and criminal activity; and
                                    ``(IV) the contribution of drugs to 
                                the underground economy, as measured by 
                                the retail value of drugs sold in the 
                                United States;
                            ``(iv) a determination of the status of 
                        drug treatment in the United States, by 
                        assessing--
                                    ``(I) public and private treatment 
                                capacity within each State, including 
                                information on the treatment capacity 
                                available in relation to the capacity 
                                actually used;
                                    ``(II) the extent, within each 
                                State, to which treatment is available;
                                    ``(III) the number of drug users 
                                the Director estimates could benefit 
                                from treatment; and
                                    ``(IV) the specific factors that 
                                restrict the availability of treatment 
                                services to those seeking it and 
                                proposed administrative or legislative 
                                remedies to make treatment available to 
                                those individuals; and
                            ``(v) a review of the research agenda of 
                        the Counter-Drug Technology Assessment Center 
                        to reduce the availability and abuse of drugs; 
                        and
                    ``(F) an assessment of private sector initiatives 
                and cooperative efforts between the Federal Government 
                and State and local governments for drug control.
            ``(2) Submission of revised strategy.--The President may 
        submit to Congress a revised National Drug Control Strategy 
        that meets the requirements of this section--
                    ``(A) at any time, upon a determination by the 
                President and the Director that the National Drug 
                Control Strategy in effect is not sufficiently 
                effective; and
                    ``(B) if a new President or Director takes office.
    ``(c) Performance Measurement System.--
            ``(1) In general.--Not later than November 1, 1997, the 
        Director shall submit to Congress a description of the national 
        drug control performance measurement system, designed in 
        consultation with affected National Drug Control Program 
        agencies, that--
                    ``(A) develops performance objectives, measures, 
                and targets for each National Drug Control Strategy 
                goal and objective;
                    ``(B) revises performance objectives, measures, and 
                targets, to conform with National Drug Control Program 
                Agency budgets;
                    ``(C) identifies major programs and activities of 
                the National Drug Control Program agencies that support 
the goals and objectives of the National Drug Control Strategy;
                    ``(D) evaluates implementation of major program 
                activities supporting the National Drug Control 
                Strategy developed under section 1005;
                    ``(E) monitors consistency between the drug-related 
                goals and objectives of the National Drug Control 
                Program agencies and ensures that drug control agency 
                goals and budgets support and are fully consistent with 
                the National Drug Control Strategy; and
                    ``(F) coordinates the development and 
                implementation of national drug control data collection 
                and reporting systems to support policy formulation and 
                performance measurement, including an assessment of--
                            ``(i) the quality of current drug use 
                        measurement instruments and techniques to 
                        measure supply reduction and demand reduction 
                        activities;
                            ``(ii) the adequacy of the coverage of 
                        existing national drug use measurement 
                        instruments and techniques to measure the 
                        casual drug user population and groups that are 
                        at risk for drug use; and
                            ``(iii) the actions the Director shall take 
                        to correct any deficiencies and limitations 
                        identified pursuant to subparagraphs (A) and 
                        (B) of subsection (b)(4).
            ``(2) Modifications.--A description of any modifications 
        made during the preceding year to the national drug control 
        performance measurement system described in paragraph (1) shall 
        be included in each report submitted under subsection (b).''.
    (f) High Intensity Drug Trafficking Areas Program.--The National 
Narcotics Leadership Act of 1988 (21 U.S.C. 1501 et seq.) is amended by 
inserting after section 1005 the following:

``SEC. 1005A. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    ``(a) Establishment.--There is established in the Office a program 
to be known as the High Intensity Drug Trafficking Areas Program.
    ``(b) Designation.--The Director, upon consultation with the 
Attorney General, the Secretary of the Treasury, heads of the National 
Drug Control Program agencies, and the Governor of each State, may 
designate any specified area of the United States as a high intensity 
drug trafficking area. After making such a designation and in order to 
provide Federal assistance to the area so designated, the Director 
may--
            ``(1) obligate such sums as appropriated for the High 
        Intensity Drug Trafficking Areas Program;
            ``(2) direct the temporary reassignment of Federal 
        personnel to such area, subject to the approval of the 
        Secretary of the department or head of the agency that employs 
        such personnel;
            ``(3) take any other action authorized under section 1003 
        to provide increased Federal assistance to such areas;
            ``(4) coordinate activities under this paragraph 
        (specifically administrative, recordkeeping, and funds 
        management activities) with State and local officials.
    ``(c) Factors for Consideration.--In considering whether to 
designate an area under this section as a high intensity drug 
trafficking area, the Director shall consider, in addition to such 
other criteria as the Director considers to be appropriate, the extent 
to which--
            ``(1) the area is a center of illegal drug production, 
        manufacturing, importation, or distribution;
            ``(2) State and local law enforcement agencies have 
        committed resources to respond to the drug trafficking problem 
        in the area, thereby indicating a determination to respond 
        aggressively to the problem;
            ``(3) drug-related activities in the area are having a 
        harmful impact in other areas of the country; and
            ``(4) a significant increase in allocation of Federal 
        resources is necessary to respond adequately to drug-related 
        activities in the area.''.
    (g) Counter-Drug Technology Assessment Center.--Section 1008 of the 
National Narcotics Leadership Act of 1988 (21 U.S.C. 1505) is amended 
to read as follows:

``SEC. 1008. COUNTER-DRUG TECHNOLOGY ASSESSMENT CENTER.

    ``(a) Establishment.--There is established within the Office the 
Counter-Drug Technology Assessment Center (in this section referred to 
as the `Center'). The Center shall operate under the authority of the 
Director of National Drug Control Policy and shall serve as the central 
counter-drug technology research and development organization of the 
United States Government.
    ``(b) Director of Technology.--There shall be at the head of the 
Center the Director of Technology, who shall be appointed by the 
Director of National Drug Control Policy from among individuals 
qualified and distinguished in the area of science, medicine, 
engineering, or technology.
    ``(c) Additional Responsibilities of the Director of National Drug 
Control Policy.--
            ``(1) In general.--The Director, acting through the 
        Director of Technology shall--
                    ``(A) identify and define the short-, medium-, and 
                long-term scientific and technological needs of 
                Federal, State, and local drug supply reduction 
                agencies, including--
                            ``(i) advanced surveillance, tracking, and 
                        radar imaging;
                            ``(ii) electronic support measures;
                            ``(iii) communications;
                            ``(iv) data fusion, advanced computer 
                        systems, and artificial intelligence; and
                            ``(v) chemical, biological, radiological 
                        (including neutron, electron, and graviton), 
                        and other means of detection;
                    ``(B) identify demand reduction basic and applied 
                research needs and initiatives, in consultation with 
                affected National Drug Control Program agencies, 
                including--
                            ``(i) improving treatment through 
                        neuroscientific advances;
                            ``(ii) improving the transfer of biomedical 
                        research to the clinical setting; and
                            ``(iii) in consultation with the National 
                        Institute on Drug Abuse, and through 
                        interagency agreements or grants, examining 
                        addiction and rehabilitation research and the 
                        application of technology to expanding the 
                        effectiveness or availability of drug 
                        treatment;
                    ``(C) make a priority ranking of such needs 
                identified in subparagraphs (A) and (B) according to 
                fiscal and technological feasibility, as part of a 
                National Counter-Drug Enforcement Research and 
                Development Program;
                    ``(D) oversee and coordinate counter-drug 
                technology initiatives with related activities of other 
                Federal civilian and military departments;
                    ``(E) provide support to the development and 
                implementation of the national drug control performance 
                measurement system; and
                    ``(F) pursuant to the authority of the Director of 
                National Drug Control Policy under section 1003, submit 
                requests to Congress for the reprogramming or transfer 
                of funds appropriated for counter-drug technology 
                research and development.
            ``(2) Limitation on authority.--The authority granted to 
        the Director under this subsection shall not extend to the 
        award of contracts, management of individual projects, or other 
        operational activities.
    ``(d) Assistance and Support to Office of National Drug Control 
Policy.--The Department of Defense and the Department of Health and 
Human Services shall, to the fullest extent possible, render assistance 
and support to the Office and to the Director in the conduct of 
counter-drug technology assessment.''.
    (h) Termination of Office of National Drug Control Policy.--Section 
1009 of the National Narcotics Leadership Act of 1988 (42 U.S.C. 1506) 
is amended to read as follows:

``SEC. 1009. TERMINATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY.

    ``Effective on September 30, 2001, this subtitle and the amendments 
made by this subtitle are repealed.''.
    (i) Council on Counter-Narcotics.--Section 1010 of the National 
Narcotics Leadership Act of 1988 (21 U.S.C. 1509) is amended to read as 
follows:

``SEC. 1010. COUNCIL ON COUNTER-NARCOTICS.

    ``(a) Establishment.--There is established a council to be known as 
the President's Council on Counter-Narcotics (in this section referred 
to as the `Council').
    ``(b) Membership.--
            ``(1) In general.--Subject to paragraph (2), the Council 
        shall be composed of 16 members, of whom--
                    ``(A) 1 shall be the President, who shall serve as 
                Chairman of the Council;
                    ``(B) 1 shall be the Vice President;
                    ``(C) 1 shall be the Secretary of State;
                    ``(D) 1 shall be the Secretary of the Treasury;
                    ``(E) 1 shall be the Secretary of Defense;
                    ``(F) 1 shall be the Attorney General;
                    ``(G) 1 shall be the Secretary of Transportation;
                    ``(H) 1 shall be the Representative of the United 
                States of America to the United Nations;
                    ``(I) 1 shall be the Director of the Office of 
                Management and Budget;
                    ``(J) 1 shall be the Chief of Staff to the 
                President;
                    ``(K) 1 shall be the Director of the Office, who 
                shall serve as the Executive Director of the Council;
                    ``(L) 1 shall be the Director of Central 
                Intelligence;
                    ``(M) 1 shall be the Assistant to the President for 
                National Security Affairs;
                    ``(N) 1 shall be the Counsel to the President;
                    ``(O) 1 shall be the Chairman of the Joint Chiefs 
                of Staff; and
                    ``(P) 1 shall be the National Security Adviser to 
                the Vice President.
            ``(2) Additional members.--The President may, in the 
        discretion of the President, appoint additional members to the 
        Council, of whom--
                    ``(A) 1 may be the Secretary of Health and Human 
                Services;
                    ``(B) 1 may be the Secretary of Education;
                    ``(C) 1 may be the Assistant to the President for 
                Domestic Policy; and
                    ``(D) 1 or more may be other officials of 
                departments and agencies of the Federal Government, as 
                determined by the President.
    ``(c) Meetings of the Council.--The Council shall meet not less 
than quarterly at the call of the President (or, upon the direction of 
the President, at the call of the Vice President). The President (or in 
the absence of the President, the Vice President) shall preside over 
each meeting of the Council.
    ``(d) Functions.--
            ``(1) In general.--The Council shall advise and assist the 
        President in--
                    ``(A) providing direction and oversight for the 
                national drug control strategy, including relating drug 
                control policy to other national security interests and 
                establishing priorities; and
                    ``(B) ensuring coordination among departments and 
                agencies concerning implementation of the President's 
                national drug control strategy.
            ``(2) Duties of director.--The Director shall--
                    ``(A) be the senior drug control policy official in 
                the executive branch; and
                    ``(B) serve as the chief drug control policy 
                spokesman for the President.
            ``(3) National security matters.--In any matter affecting 
        national security interests, the Director shall work in 
        conjunction with the Assistant to the President for National 
        Security Affairs.
    ``(e) Administration.--
            ``(1) In general.--The Council may utilize established or 
        ad hoc committees, task forces, or interagency groups chaired 
        by the Director (or a representative of the Director) in 
        carrying out the functions of the Council under this section.
            ``(2) Staff.--The staff of the Office, in coordination with 
        the staffs of the Vice President and the Assistant to the 
        President for National Security Affairs, shall act as staff for 
        the Council.
            ``(3) Cooperation from other agencies.--Each department and 
        agency of the executive branch shall--
                    ``(A) cooperate with the Council in carrying out 
                the functions of the Council under this section; and
                    ``(B) provide such assistance, information, and 
                advice as the Council may request, to the extent 
                permitted by law.''.
    (j) Parents Advisory Council on Youth Drug Abuse.--The National 
Narcotics Leadership Act of 1988 (21 U.S.C. 1501 et seq.) is amended by 
inserting after section 1010 the following:

``SEC. 1010A. PARENTS ADVISORY COUNCIL ON YOUTH DRUG ABUSE.

    ``(a) Establishment.--
            ``(1) Establishment.--There is established a Council to be 
        known as the Parents Advisory Council on Youth Drug Abuse (in 
        this section referred to as the `Council').
            ``(2) Membership.--
                    ``(A) Composition.--The Council shall be composed 
                of 16 members, of whom--
                            ``(i) 4 shall be appointed by the 
                        President, each of whom shall be a parent or 
                        guardian of a child who is not less than 6 and 
                        not more than 18 years of age as of the date on 
                        which the appointment is made;
                            ``(ii) 4 shall be appointed by the Majority 
                        Leader of the Senate, 3 of whom shall be a 
                        parent or guardian of a child who is not less 
                        than 6 and not more than 18 years of age as of 
                        the date on which the appointment is made;
                            ``(iii) 2 shall be appointed by the 
                        Minority Leader of the Senate, each of whom 
                        shall be a parent or guardian of a child who is 
                        not less than 6 and not more than 18 years of 
age as of the date on which the appointment is made;
                            ``(iv) 4 shall be appointed by the Speaker 
                        of the House of Representatives, 3 of whom 
                        shall be a parent or guardian of a child who is 
                        not less than 6 and not more than 18 years of 
                        age as of the date on which the appointment is 
                        made; and
                            ``(v) 2 shall be appointed by the Minority 
                        Leader of the House of Representatives, each of 
                        whom shall be a parent or guardian of a child 
                        who is not less than 6 and not more than 18 
                        years of age as of the date on which the 
                        appointment is made.
                    ``(B) Requirements.--
                            ``(i) In general.--Each member of the 
                        Council shall be an individual from the private 
                        sector with a demonstrated interest and 
                        expertise in research, education, treatment, or 
                        prevention activities related to youth drug 
                        abuse.
                            ``(ii) Representatives of nonprofit 
                        organizations.--Not less than 1 member 
                        appointed under each of clauses (i) through (v) 
                        of paragraph (1)(A) shall be a representative 
                        of a nonprofit organization focused on 
                        involving parents in antidrug education and 
                        prevention.
                    ``(C) Date.--The appointments of the initial 
                members of the Council shall be made not later than 60 
                days after the date of enactment of this section.
                    ``(D) Director.--The Director may, in the 
                discretion of the Director, serve as an adviser to the 
                Council and attend such meetings and hearings of the 
                Council as the Director considers to be appropriate.
            ``(3) Period of appointment; vacancies.--
                    ``(A) Period of appointment.--Each member of the 
                Council shall be appointed for a term of 3 years, 
                except that, of the initial members of the Council--
                            ``(i) 1 member appointed under each of 
                        clauses (i) through (v) of paragraph (1)(A) 
                        shall be appointed for a term of 1 year; and
                            ``(ii) 1 member appointed under each of 
                        clauses (i) through (v) of paragraph (1)(A) 
                        shall be appointed for a term of 2 years.
                    ``(B) Vacancies.--Any vacancy in the Council shall 
                not affect its powers, provided that a quorum is 
                present, but shall be filled in the same manner as the 
                original appointment. Any member appointed to fill a 
                vacancy occurring before the expiration of the term for 
                which the member's predecessor was appointed shall be 
                appointed only for the remainder of that term.
                    ``(C) Appointment of successor.--To the extent 
                necessary to prevent a vacancy in the membership of the 
                Council, a member of the Council may serve for not more 
                than 6 months after the expiration of the term of that 
                member, if the successor of that member has not been 
                appointed.
            ``(4) Initial meeting.--Not later than 120 days after the 
        date on which all initial members of the Council have been 
        appointed, the Council shall hold its first meeting.
            ``(5) Meetings.--The Council shall meet at the call of the 
        Chairperson.
            ``(6) Quorum.--Nine members of the Council shall constitute 
        a quorum, but a lesser number of members may hold hearings.
            ``(7) Chairperson and vice chairperson.--
                    ``(A) In general.--The members of the Council shall 
                select a Chairperson and Vice Chairperson from among 
                the members of the Council.
                    ``(B) Duties of chairperson.--The Chairperson of 
                the Council shall--
                            ``(i) serve as the executive director of 
                        the Council;
                            ``(ii) direct the administration of the 
                        Council;
                            ``(iii) assign officer and committee duties 
                        relating to the Council; and
                            ``(iv) issue the reports, policy positions, 
                        and statements of the Council.
                    ``(C) Duties of vice chairperson.--If the 
                Chairperson of the Council is unable to serve, the Vice 
                Chairperson shall serve as the Chairperson.
    ``(b) Duties of the Council.--
            ``(1) In general.--The Council--
                    ``(A) shall advise the President and the Members of 
                the Cabinet, including the Director, on drug 
                prevention, education, and treatment; and
                    ``(B) may issue reports and recommendations on drug 
                prevention, education, and treatment, in addition to 
                the annual report detailed in paragraph (2), as the 
                Council considers appropriate.
            ``(2) Submission to congress.--Any report or recommendation 
        issued by the Council shall be submitted to Congress.
            ``(3) Advice on the national drug control strategy.--Not 
        later than December 1, 1998, and on December 1 of each year 
        thereafter, the Council shall submit to the Director an annual 
        report containing drug control strategy recommendations on drug 
        prevention, education, and treatment. Each report submitted to 
        the Director under this paragraph shall be included as an 
        appendix to the report submitted by the Director under section 
        1005(b).
    ``(c) Powers of the Council.--
            ``(1) Hearings.--The Council may hold such hearings, sit 
        and act at such times and places, take such testimony, and 
        receive such evidence as the Council considers advisable to 
        carry out the purposes of this section.
            ``(2) Information from federal agencies.--The Council may 
        secure directly from any department or agency of the Federal 
        Government such information as the Council considers to be 
        necessary to carry out this section. Upon request of the 
        Chairperson of the Council, the head of that department or 
        agency shall furnish such information to the Council, unless 
        the head of that department or agency determines that 
        furnishing the information to the Council would threaten the 
        national security of the United States, the health, safety, or 
        privacy of any individual, or the integrity of an ongoing 
        investigation.
            ``(3) Postal services.--The Council may use the United 
        States mails in the same manner and under the same conditions 
        as other departments and agencies of the Federal Government.
            ``(4) Gifts.--The Council may solicit, accept, use, and 
        dispose of gifts or donations of services or property in 
        connection with performing the duties of the Council under this 
        section.
    ``(d) Expenses.--The members of the Council shall be allowed travel 
expenses, including per diem in lieu of subsistence, at rates 
authorized for employees of agencies under subchapter I of chapter 57 
of title 5, United States Code, while away from their homes or regular 
places of business in the performance of services for the Council.
    ``(e) Authorization of Appropriations.--There are authorized to be 
appropriated to the Council such sums as may be necessary carry out 
this section.''.
    (k) Authorization of Appropriations.--Section 1011 of the National 
Narcotics Leadership Act of 1988 (21 U.S.C. 1508) is amended to read as 
follows:

``SEC. 1011. AUTHORIZATION OF APPROPRIATIONS.

    ``There are authorized to be appropriated to carry out this 
subtitle, to remain available until expended, such sums as may be 
necessary for each of fiscal years 1998 through 2001.''.
    (l) Establishment of Special Forfeiture Fund.--Section 6073 of the 
Asset Forfeiture Amendments Act of 1988 (42 U.S.C. 1509) is amended--
            (1) in subsection (b)--
                    (A) by striking ``section 524(c)(9)'' and inserting 
                ``section 524(c)(8)''; and
                    (B) by striking ``section 9307(g)'' and inserting 
                ``section 9703(g)''; and
            (2) in subsection (e), by striking ``strategy'' and 
        inserting ``Strategy''.
    (m) Conforming Amendments.--Chapter 53 of title 5, United States 
Code, is amended--
            (1) in section 5313, by adding at the end the following:
    ``Deputy Director of National Drug Control Policy''; and
            (2) in section 5314--
                    (A) by inserting after ``Administrator, Office of 
                Information and Regulatory Affairs, Office of 
                Management and Budget'' the following:
    ``Deputy Director for State and Local Affairs, Office of National 
Drug Control Policy''; and
                    (B) in section 5315, by striking ``Associate 
                Director for National Drug Control Policy, Office of 
                National Drug Control Policy''.

SEC. 3. DRUG INTERDICTION.

    (a) Definitions.--In this section--
            (1) the term ``Director'' means the Director of the Office 
        of National Drug Control Policy; and
            (2) the term ``Federal drug control agency'' means--
                    (A) the Office of National Drug Control Policy;
                    (B) the Department of Defense;
                    (C) the Drug Enforcement Administration;
                    (D) the Federal Bureau of Investigation;
                    (E) the Immigration and Naturalization Service;
                    (F) the United States Coast Guard;
                    (G) the United States Customs Service; and
                    (H) any other department or agency of the Federal 
                Government that the Director determines to be relevant.
    (b) Report.--In order to assist Congress in determining the 
personnel, equipment, funding, and other resources that would be 
required by Federal drug control agencies in order to achieve a level 
of interdiction success at or above the highest level achieved before 
the date of enactment of this Act, not later than 90 days after the 
date of enactment of this Act, the Director shall submit to Congress 
and to each Federal drug control program agency a report, which shall 
include--
            (1) with respect to the southern and western border regions 
        of the United States (including the Pacific coast, the border 
        with Mexico, the Gulf of Mexico coast, and other ports of 
        entry) and in overall totals, data relating to--
                    (A) the amount of marijuana, heroin, 
                methamphetamine, and cocaine--
                            (i) seized during the year of highest 
                        recorded seizures for each drug in each region 
                        and during the year of highest recorded overall 
                        seizures; and
                            (ii) disrupted during the year of highest 
                        recorded disruptions for each drug in each 
                        region and during the year of highest recorded 
                        overall seizures; and
                    (B) the number of persons arrested for violations 
                of section 1010(a) of the Controlled Substances Import 
                and Export Act (21 U.S.C. 960(a)) and related offenses 
                during the year of the highest number of arrests on 
                record for each region and during the year of highest 
                recorded overall arrests;
            (2) the price of cocaine, heroin, methamphetamine, and 
        marijuana during the year of highest price on record during the 
        preceding 10-year period, adjusted for purity; and
            (3) a description of the personnel, equipment, funding, and 
        other resources of the Federal drug control agency devoted to 
        drug interdiction and securing the borders of the United States 
        against drug trafficking for each of the years identified in 
        paragraphs (1) and (2) for each Federal drug control agency.
    (b) Budget Process.--
            (1) Information to director.--Based on the report submitted 
        under subsection (b), each Federal drug control agency shall 
        submit to the Director, as part of each annual drug control 
        budget request submitted by the Federal drug control agency to 
        the Director under section 1003(c)(2) of the National Narcotics 
        Leadership Act of 1988 (as amended by this Act), a description 
        of the specific personnel, equipment, funding, and other 
        resources that would be required for the Federal drug control 
        agency to meet or exceed the highest level of interdiction 
        success for that agency identified in the report submitted 
        under subsection (b).
            (2) Information to congress.--The Director shall include 
        each submission under paragraph (1) in each annual consolidated 
        National Drug Control Program budget proposal submitted by the 
        Director to Congress under section 1003(c) of the National 
        Narcotics Leadership Act of 1988 (as amended by this Act), 
        which submission shall be accompanied by a description of any 
        additional resources that would be required by the Federal drug 
        control agencies to meet the highest level of interdiction 
        success identified in the report submitted under subsection 
        (b).

SEC. 4. REPORT ON AN ALLIANCE AGAINST NARCOTICS TRAFFICKING IN THE 
              WESTERN HEMISPHERE.

    (a) Sense of Congress on Discussions for Alliance.--
            (1) Sense of congress.--It is the sense of Congress that 
        the President should discuss with the democratically-elected 
        governments of the Western Hemisphere the prospect of forming a 
        multilateral alliance to address problems relating to 
        international drug trafficking in the Western Hemisphere.
            (2) Consultations.--In the consultations on the prospect of 
        forming an alliance described in paragraph (1), the President 
        should seek the input of such governments on the possibility of 
        forming 1 or more structures within the alliance--
                    (A) to develop a regional, multilateral strategy to 
                address the threat posed to nations in the Western 
                Hemisphere by drug trafficking; and
                    (B) to establish a new mechanism for improving 
                multilateral coordination of drug interdiction and 
drug-related law enforcement activities in the Western Hemisphere.
    (b) Report.--
            (1) Requirement.--Not later than 60 days after the date of 
        enactment of this Act, the President shall submit to Congress a 
        report on the proposal discussed under subsection (a). The 
        report shall include the following:
                    (A) An analysis of the reactions of the governments 
                concerned to the proposal.
                    (B) An assessment of the proposal, including an 
                evaluation of the feasibility and advisability of 
                forming the alliance.
                    (C) A determination in light of the analysis and 
                assessment whether or not the formation of the alliance 
                is in the national interests of the United States.
                    (D) If the President determines that the formation 
                of the alliance is in the national interests of the 
                United States, a plan for encouraging and facilitating 
                the formation of the alliance.
                    (E) If the President determines that the formation 
                of the alliance is not in the national interests of the 
                United States, an alternative proposal to improve 
                significantly efforts against the threats posed by 
                narcotics trafficking in the Western Hemisphere, 
                including an explanation of how the alternative 
                proposal will--
                            (i) improve upon current cooperation and 
                        coordination of counter-drug efforts among 
                        nations in the Western Hemisphere;
                            (ii) provide for the allocation of the 
                        resources required to make significant progress 
                        in disrupting and disbanding the criminal 
                        organizations responsible for the trafficking 
                        of illegal drugs in the Western Hemisphere; and
                            (iii) differ from and improve upon past 
                        strategies adopted by the United States 
                        Government which have failed to make sufficient 
                        progress against the trafficking of illegal 
                        drugs in the Western Hemisphere.
            (2) Unclassified form.--The report under paragraph (1) 
        shall be submitted in unclassified form, but may contain a 
        classified annex.

            Passed the House of Representatives October 21, 1997.

            Attest:

                                                ROBIN H. CARLE,

                                                                 Clerk.